Showing 7731-7740 of 10621 results for "".
- Cannabis and Older Adults: Poll Shows Current Use Patterns, Beliefs, and Riskshttps://reachmd.com/news/cannabis-and-older-adults-poll-shows-current-use-patterns-beliefs-and-risks/2468164/Newswise — Whether they’re using it for recreational or medical reasons, a sizable percentage of people in their 50s and older have smoked, eaten, drunk or applied to their skin at least one form of cannabis in the past year, a new poll shows.In all, 21% of people age 50 and old
- University of Minnesota Scientists Discover Dual Roles of Antibodies in COVID-19 Infectionshttps://reachmd.com/news/university-of-minnesota-scientists-discover-dual-roles-of-antibodies-in-covid-19-infections/2468146/MINNEAPOLIS/ST. PAUL (09/10/2024) - Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising discovery: antibodies can have opposite effects on viral infections in
- Games, Puzzles, and Reading Can Slow Cognitive Decline in the Elderly — Even in Those with Mild Cognitive Impairmenthttps://reachmd.com/news/games-puzzles-and-reading-can-slow-cognitive-decline-in-the-elderly-even-in-those-with-mild-cognitive-impairment/2468149/The high-level participation group consistently exhibited higher cognitive function levels during the study period.Getty Images The aging process can lead to diminished cognitive functio
- New Spanish Language Stroke Prevention Website Aims to Remove Barriers to Equitable Healthhttps://reachmd.com/news/new-spanish-language-stroke-prevention-website-aims-to-remove-barriers-to-equitable-health/2468128/DALLAS, September 9, 2024 — While stroke is the fifth-leading overall cause of death in the United States, it disproportionately impacts Hispanic people. It is the third leading cause of death among Hispanic women and the fourth leading cause of
- How the Scars of Demolished Brain Tumors Seed Relapsehttps://reachmd.com/news/how-the-scars-of-demolished-brain-tumors-seed-relapse/2468136/SEPTEMBER 9, 2024, NEW YORK – A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by interventions such as radiotherapy, surge
- 100x Improvement in Sight Seen After Gene Therapy Trialhttps://reachmd.com/news/100x-improvement-in-sight-seen-after-gene-therapy-trial/2468109/Artur Cideciyan, PhD, (left) and Tomas S. Aleman, MD (right). PHILADELPHIA— The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times
- Could Your Child Be Suffering from Long COVID? Key Symptoms to Knowhttps://reachmd.com/news/could-your-child-be-suffering-from-long-covid-key-symptoms-to-know/2468070/Recent research highlights distinct long COVID symptoms in youths, with indices developed to assist in future diagnostic and treatment studies, aiming to better address the persis
- Novel Immunotherapy Improves Recovery from Spinal Cord Injuryhttps://reachmd.com/news/novel-immunotherapy-improves-recovery-from-spinal-cord-injury/2468083/BYLINE: Marta Wegorzewska Newswise — Severe injuries to the spinal cord damage nerve cells, disrupt communication with the brain and rest of the body, and lead to lasting disabilities for millions of people worldwide. The injury itself accounts for only a frac
- Fungal Spores of the Mold Aspergillus Fumigatus Produce an Enzyme That Weakens the Immune Systemhttps://reachmd.com/news/fungal-spores-of-the-mold-aspergillus-fumigatus-produce-an-enzyme-that-weakens-the-immune-system/2468069/by Friederike Gawlik, Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie - Hans-Knöll-Institut (Leibniz-HKI) Scanning
- Groundbreaking Study Unveils Multimodal Approach to Tackle Post-COVID Syndromehttps://reachmd.com/news/groundbreaking-study-unveils-multimodal-approach-to-tackle-post-covid-syndrome/2468034/In a world still grappling with the aftermath of the COVID-19 pandemic, a team of international researchers has proposed a novel approach to treating the persistent symptoms that plague many survivors of viral infections. The study, published on 30 August 2024 in Brain Medicine (ISSN: